Ted W. Love M.D.
Ted W. Love M.D.

Ted W. Love M.D.

Chief Executive Officer, Global Blood Therapeutics

Ted W. Love, M.D., has served as a member of the Board since June 2012. From February 2010 to August 2012, Dr. Love served as Executive Vice President and Head of Research and Development of Onyx Pharmaceuticals. From 2001 to 2009, Dr. Love was the President, Chief Executive Officer and Chairman of the Board of Directors of Nuvelo. Before joining Nuvelo in 2001, he served as Senior Vice President of Development at Theravance, Inc. Prior to that, Dr. Love spent six years at Genentech, Inc. in a number of senior management positions in Medical Affairs and Product Development. As Vice President of Product Development and Regulatory Affairs at Genentech, Dr. Love oversaw all drugs in development including Herceptin, Rituxan, and TNKase. He also served as chairman of Genentech’s Product Development Committee.

Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School.

Dr. Love serves as member of the Nominating and Governance Committee and as member of the Science and Technology Committee.

Back to Board of Directors